acute ischemic stroke
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients inclusion criteria: ? Age =18 years old; ? Meet the diagnostic criteria of China Acute Ischemic Stroke Diagnostic and Treatment Guidelines 2018, and diagnosed by cranial CT and/or MRI; ? Within the time window of intravenous thrombolysis, the patient meets the indications for thrombolysis after evaluation by the physician; ? Condition is stable, clear consciousness, normal communication, cognitive judgment, and no history of serious psychiatric illness; ? Patient or surrogate decision-maker Participate in the intravenous thrombolysis informed consent conversation and sign the intravenous thrombolysis informed consent form; ? Participate voluntarily, give informed consent to this study and sign the informed consent form. Surrogate decision-makers inclusion criteria: ? Age = 18 years, must be immediate family members (parents, spouse, children, or family members who have signed the power of attorney with the patient's consent); ? Participate in the intravenous thrombolysis informed consent interview and sign the intravenous thrombolysis informed consent form on behalf of the patient; ? Consciousness, can be communicated normally, with the ability to make cognitive judgments, no history of serious mental illness; ? Participate voluntarily, give informed consent to the study, and sign the informed consent form. (iv) Voluntary participation, informed consent to the study, and signing the informed consent form.
Exclusion criteria
Exclusion criteria: patients exclusion criteria: ?patients with severe functional disorders of heart, brain, kidney and other organs, cognitive dysfunction or psychiatric illnesses who could not cooperate with the study; ?patients who were referred to our hospital for intravenous thrombolysis after the onset of the disease by other medical institutions; ?patients who were not accompanied by emergency stroke nurses or were not accompanied by them throughout the whole process; ? patients who voluntarily withdrew from the study in the course of the study. Surrogate decision-makers exclusion criteria: ? unable to participate due to visual, hearing impairment, cognitive impairment; ? voluntarily withdrew from the study during the course of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Obtain informed consent time;Decision conflict; | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient satisfaction with treatment decisions;Door to needle time(DNT);DNT<45 minute ratio;DNT<60 minute ratio; | — |
Countries
China
Contacts
The Second Affiliated Hospital of Soochow University